XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net income $ 201,445 $ 304,802
Adjustments to reconcile net income to net cash provided by operating activities:    
Net amortization/accretion of premium/discount on securities 26,771 14,365
Depreciation, amortization and accretion 32,127 4,365
Provision for credit losses 184,554 22,639
Gain on mortgage loans sold, net (47,655) (18,291)
Investment losses (gains) on sales, net (986) 6,009
Stock-based compensation expense 14,092 15,091
Deferred tax expense (benefit) (31,288) 5,355
Losses on dispositions of other real estate and other investments 6,600 2,612
Income from equity method investment (59,245) (77,799)
Dividends received from equity method investment 47,981 49,940
Excess tax benefit from stock compensation (505) (832)
Gain (Loss) on Sale of Loans and Leases 1,856 2,841
Increase in other assets (188,675) (79,462)
Increase in other liabilities 64,488 91,624
Net cash provided by operating activities 301,725 314,504
Activities in securities available-for-sale:    
Purchases (1,189,922) (1,039,225)
Sales 145,631 626,097
Maturities, prepayments and calls 356,690 253,350
Activities in securities held-to-maturity:    
Purchases 0 (3,822)
Maturities, prepayments and calls 13,345 7,800
Increase in loans, net (2,705,594) (1,488,436)
Purchases of software, premises and equipment (30,309) (34,190)
Proceeds from sales of software, premises and equipment 0 66
Proceeds from sale of other real estate 7,191 4,947
Purchase of bank owned life insurance policies 0 (110,000)
Proceeds from bank owned life insurance settlements 4,580 308
Proceeds from Derivative Instrument 35,680  
Payments for Derivative Instrument   (37,982)
Purchase of trade name (1,000) 0
Increase in other investments (50,335) (43,260)
Net cash used in investing activities (3,414,043) (1,908,941)
Financing activities:    
Net increase in deposits 6,363,187 1,152,021
Net increase (decrease) in securities sold under agreements to repurchase 705 (9,339)
Advances from Federal Home Loan Bank:    
Federal Home Loan Bank: Advances, net of restructuring charges 762,472 2,572,500
Federal Home Loan Bank: Repayments/maturities (1,537,520) (1,963,541)
Advances of other borrowings, net of issuance costs 56,568 316,200
Repayments of other borrowings (136,661) (184,175)
Principal payments of finance lease obligation (180) (168)
Issuance of preferred stock, net of issuance costs 217,126 0
Issuance of common stock pursuant to restricted stock unit agreement, net of shares withheld for taxes (2,488) 0
Exercise of common stock options, net of repurchase of restricted shares (2,580) (4,546)
Repurchase of common stock (50,790) (48,489)
Common stock dividends paid (37,105) (37,415)
Preferred stock dividends paid (3,798) 0
Net cash provided by financing activities 5,628,936 1,793,048
Net increase in cash, cash equivalents, and restricted cash 2,516,618 198,611
Cash, cash equivalents, and restricted cash, beginning of period 526,707 721,692
Cash, cash equivalents, and restricted cash, end of period 3,043,325 920,303
Commercial loans held for sale:    
Adjustments to reconcile net income to net cash provided by operating activities:    
Loans held-for-sale originated (271,996) (315,454)
Loans held-for-sale sold 279,147 312,936
Consumer loans held for sale:    
Adjustments to reconcile net income to net cash provided by operating activities:    
Loans held-for-sale originated (1,550,290) (1,001,377)
Loans held-for-sale sold $ 1,597,016 $ 980,822